drugset / Trial / NCT01068067
Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients
Unknown
60 enrolled
Sun Yat-sen University
First Affiliated Hospital, Sun Yat-Sen University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare pharmacogenetics plus drug combination (Schisandra sphenanthera extract,SchE)guided and standard initial tacrolimus dosage.
Timeline
- Start
- 2010-03
- Primary completion
- 2012-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tacrolimus | Small molecule | 0.05 mg/kg | — |
| Comparator | Tacrolimus | Small molecule | 0.075 mg/kg | — |
Indications
No indication recorded.